1. Home
  2. LGND vs LKFN Comparison

LGND vs LKFN Comparison

Compare LGND & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • LKFN
  • Stock Information
  • Founded
  • LGND 1987
  • LKFN 1872
  • Country
  • LGND United States
  • LKFN United States
  • Employees
  • LGND N/A
  • LKFN N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • LKFN Major Banks
  • Sector
  • LGND Health Care
  • LKFN Finance
  • Exchange
  • LGND Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • LGND 2.0B
  • LKFN 1.7B
  • IPO Year
  • LGND 1992
  • LKFN 1997
  • Fundamental
  • Price
  • LGND $111.71
  • LKFN $73.22
  • Analyst Decision
  • LGND Strong Buy
  • LKFN Hold
  • Analyst Count
  • LGND 6
  • LKFN 3
  • Target Price
  • LGND $144.83
  • LKFN $71.00
  • AVG Volume (30 Days)
  • LGND 142.9K
  • LKFN 127.6K
  • Earning Date
  • LGND 11-07-2024
  • LKFN 10-25-2024
  • Dividend Yield
  • LGND N/A
  • LKFN 2.62%
  • EPS Growth
  • LGND 160.46
  • LKFN 9.99
  • EPS
  • LGND 2.47
  • LKFN 3.85
  • Revenue
  • LGND $152,422,000.00
  • LKFN $242,401,000.00
  • Revenue This Year
  • LGND $23.19
  • LKFN N/A
  • Revenue Next Year
  • LGND $15.08
  • LKFN $1.35
  • P/E Ratio
  • LGND $45.20
  • LKFN $19.02
  • Revenue Growth
  • LGND N/A
  • LKFN 3.62
  • 52 Week Low
  • LGND $57.00
  • LKFN $53.97
  • 52 Week High
  • LGND $129.90
  • LKFN $78.31
  • Technical
  • Relative Strength Index (RSI)
  • LGND 48.80
  • LKFN 60.86
  • Support Level
  • LGND $119.69
  • LKFN $63.48
  • Resistance Level
  • LGND $125.76
  • LKFN $77.20
  • Average True Range (ATR)
  • LGND 5.73
  • LKFN 2.56
  • MACD
  • LGND -0.30
  • LKFN 0.64
  • Stochastic Oscillator
  • LGND 25.51
  • LKFN 65.68

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. Lakeland offers a broad range of products and services throughout its Northern and Central Indiana markets. The company offers commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: